Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion type Assertion NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_head.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion description "[In this study, BPI-ANCA were demonstrated most often in patients with ulcerative colitis (36/92, 39%), Crohn's disease (17/66, 26%) and cystic fibrosis (11/14, 79%), but also in patients with rheumatoid arthritis (8/40, 20%), systemic lupus erythematosus (SLE) (111/65, 17%) and mixed connective tissue disease (4/18, 22%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_provenance.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion evidence source_evidence_literature NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_provenance.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion SIO_000772 10836522 NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_provenance.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion wasDerivedFrom befree-2016 NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_provenance.
- NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_assertion wasGeneratedBy ECO_0000203 NP285457.RAv4vyzh0Ny_IkGw7m5XV0rsc9ALFIEces5IJDbsHQVoo130_provenance.